Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property magazine. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

  • Patent portfolio planning, strategic advice, opinions, and prosecution
  • Post-grant proceedings at the USPTO
  • Litigation services, including representation in Hatch-Waxman cases
  • FDA expertise
  • Counsel on licensing and other transactions

We have a rapidly expanding practice representing branded pharmaceutical companies in Hatch-Waxman litigation. Biotechnology and pharmaceutical companies trust Fish’s litigation team to handle these complicated, high-stakes cases because we are the world’s most experienced patent litigators.

Examples of our biotechnology and pharmaceutical work include:

  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Successfully litigating ANDA cases on behalf of branded pharmaceuticals
  • Obtaining patents for therapeutic agents and methods currently in clinical trials, including tumor-specific agents such as oncolytics viruses and humanized antibodies and methods for treating strokes
  • Patenting groundbreaking tissue engineering patents on breakthroughs that show promise in treating spinal cord injuries
  • Obtaining the first patent on a genetically engineered animal
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting intellectual property due diligence on thousands of licensing agreements for the merger of two large pharmaceuticals companies in just a few months’ time

Fish Wipes Out $2.5B Patent Verdict Against Gilead Sciences

Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in federal court in Delaware.

Read about this historic win here.

Featured Video
A Conversation with Life Science Litigator Jonathan Singer

Featured Video
Principal, Gwilym Attwell Discusses Life Science Intellectual Property

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
Event
April 26th, 2018 | 8:00 am EDT
Life Sciences Patent Network North America
Life Sciences Patent Network North America
Speaking Engagement
News
February 23, 2018
Fish & Richardson Wipes Out $2.5 Billion Patent Verdict Against Gilead Sciences on JMOL
Press Release
News
February 15, 2018
White House Targets Generic Exclusivity to Lower Drug Prices
Media Mention
News
February 7, 2018
Fish Principal Terry Mahn Testifies at U.S. Senate Special Committee on Aging, “From Joint Pain to Pocket Pain: Cost and Competition Among Rheumatoid Arthritis Therapies”
Media Mention
News
January 18, 2018
Fish & Richardson Named Law360 Life Sciences Practice Group of the Year
Press Release
News
December 13, 2017
Fish & Richardson Principals Juanita Brooks and Dorothy Whelan Named “2017 MVPs of the Year” by Law360
Press Release
News
November 30, 2017
Minnesota Lawyer Named Teresa A. Lavoie and Dorothy P. Whelan "2017 Attorneys of the Year"
Press Release
News
October 17, 2017
Fish & Richardson Principal Anita Meiklejohn, Ph.D., Named 2017 “Top Woman of Law” Honoree by Massachusetts Lawyers Weekly
Press Release
News
October 13, 2017
11 Fish & Richardson Principals Named 2017 "Life Sciences Stars" by LMG Life Sciences
Press Release
News
September 27, 2017
Fish & Richardson Announces Mayo/Myriad Life Sciences Tracker
Press Release
News
September 19, 2017
Fish & Richardson Named 2017 General Patent Litigation Firm of the Year, Inter Partes Review Firm of the Year, and IP Boutique Firm of the Year by LMG Life Sciences
Press Release
News
August 11, 2017
Star Tribune: Mayo prevails in patent case, but legal fight isn't over
Articles
load more topics